GE Healthcare China Exit?

Is GE Healthcare rethinking its China strategy? Amidst declining revenues and US-China tensions, the medical device giant is reportedly exploring a potential sale, partnership, or partial sale of its China business, valued in the billions. This follows similar moves by other US companies like Bristol Myers Squibb, signaling a significant shift in how American businesses view their future in the world's second-largest economy. What does this mean for the future of foreign investment in China? Hosted on Acast. See acast.com/privacy for more information.